BACKGROUND: The metabolic syndrome includes dyslipidemia, abdominal obesity, insulin resistance, and hypertension and is associated with an increased risk of diabetes and cerebrovascular disease (CVD), but consequences beyond these outcomes have not been examined extensively. We investigated whether metabolic abnormalities have independent consequences on loss of mobility function of older persons. METHODS: Data are from 2,920 men and women, 70-79 years, participating in the Health ABC study without mobility limitations at baseline. Metabolic syndrome was defined as > or =3 of the following: (a) waist circumference >102 (men) or >88 cm (women); (b) triglycerides > or =150 mg/dL; (c) high-density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women); (d) blood pressure > or =130/85 mm Hg or antihypertensive medication; and (d) fasting glucose > or =110 mg/dL or antidiabetic medication. Mobility limitation was defined as difficulty or inability walking (1/4) mile or climbing 10 steps during two consecutive semiannual assessments over 4.5 years. RESULTS: The prevalence of metabolic syndrome was 38.6%. The metabolic syndrome was associated with an adjusted relative risk (RR) of 1.46 (95% confidence interval [CI] = 1.30-1.63) for developing mobility limitations. The risk increased when more metabolic syndrome components were present (p trend >.001). All metabolic syndrome components were significantly associated with incident mobility limitations with the highest RRs for abdominal obesity (RR = 1.54, 95% CI = 1.35-1.75) and hyperglycemia (RR = 1.44, 95% CI = 1.27-1.63). Findings were unchanged when persons with baseline, or incident, CVD, stroke, or diabetes were excluded. CONCLUSIONS: Metabolic syndrome abnormalities, especially abdominal obesity and hyperglycemia, are predictive of mobility limitations in the elderly, independent of CVD or diabetes.
BACKGROUND: The metabolic syndrome includes dyslipidemia, abdominal obesity, insulin resistance, and hypertension and is associated with an increased risk of diabetes and cerebrovascular disease (CVD), but consequences beyond these outcomes have not been examined extensively. We investigated whether metabolic abnormalities have independent consequences on loss of mobility function of older persons. METHODS: Data are from 2,920 men and women, 70-79 years, participating in the Health ABC study without mobility limitations at baseline. Metabolic syndrome was defined as > or =3 of the following: (a) waist circumference >102 (men) or >88 cm (women); (b) triglycerides > or =150 mg/dL; (c) high-density lipoprotein cholesterol <40 mg/dL (men) or <50 mg/dL (women); (d) blood pressure > or =130/85 mm Hg or antihypertensive medication; and (d) fasting glucose > or =110 mg/dL or antidiabetic medication. Mobility limitation was defined as difficulty or inability walking (1/4) mile or climbing 10 steps during two consecutive semiannual assessments over 4.5 years. RESULTS: The prevalence of metabolic syndrome was 38.6%. The metabolic syndrome was associated with an adjusted relative risk (RR) of 1.46 (95% confidence interval [CI] = 1.30-1.63) for developing mobility limitations. The risk increased when more metabolic syndrome components were present (p trend >.001). All metabolic syndrome components were significantly associated with incident mobility limitations with the highest RRs for abdominal obesity (RR = 1.54, 95% CI = 1.35-1.75) and hyperglycemia (RR = 1.44, 95% CI = 1.27-1.63). Findings were unchanged when persons with baseline, or incident, CVD, stroke, or diabetes were excluded. CONCLUSIONS:Metabolic syndrome abnormalities, especially abdominal obesity and hyperglycemia, are predictive of mobility limitations in the elderly, independent of CVD or diabetes.
Authors: Radim Jurca; Michael J Lamonte; Timothy S Church; Conrad P Earnest; Shannon J Fitzgerald; Carolyn E Barlow; Alexander N Jordan; James B Kampert; Steven N Blair Journal: Med Sci Sports Exerc Date: 2004-08 Impact factor: 5.411
Authors: Nathalie De Rekeneire; Helaine E Resnick; Ann V Schwartz; Ronald I Shorr; Lewis H Kuller; Eleanor M Simonsick; Bruno Vellas; Tamara B Harris Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: Paul Holvoet; Stephen B Kritchevsky; Russell P Tracy; Ann Mertens; Susan M Rubin; Javed Butler; Bret Goodpaster; Tamara B Harris Journal: Diabetes Date: 2004-04 Impact factor: 9.461
Authors: Susan A Everson-Rose; Misti Paudel; Brent C Taylor; Tien Dam; Peggy Mannen Cawthon; Erin Leblanc; Elsa S Strotmeyer; Jane A Cauley; Marcia L Stefanick; Elizabeth Barrett-Connor; Kristine E Ensrud Journal: J Am Geriatr Soc Date: 2011-08-01 Impact factor: 5.562
Authors: Kelly R Ylitalo; Carrie Karvonen-Gutierrez; Candace McClure; Samar R El Khoudary; Elizabeth A Jackson; Barbara Sternfeld; Siobán D Harlow Journal: Diabetes Metab Res Rev Date: 2015-12-10 Impact factor: 4.876
Authors: Annemarie Koster; Sari Stenholm; Dawn E Alley; Lauren J Kim; Eleanor M Simonsick; Alka M Kanaya; Marjolein Visser; Denise K Houston; Barbara J Nicklas; Frances A Tylavsky; Suzanne Satterfield; Bret H Goodpaster; Luigi Ferrucci; Tamara B Harris Journal: Obesity (Silver Spring) Date: 2010-04-15 Impact factor: 5.002
Authors: S Jung; N Yabushita; M Kim; S Seino; M Nemoto; Y Osuka; Y Okubo; R Figueroa; K Tanaka Journal: J Nutr Health Aging Date: 2016-01 Impact factor: 4.075
Authors: Lisa Fredman; Gheorghe Doros; Jane A Cauley; Teresa A Hillier; Marc C Hochberg Journal: J Gerontol A Biol Sci Med Sci Date: 2010-03-29 Impact factor: 6.053